Thomas Herzog, MD
Advertisement
Articles by Thomas Herzog, MD
Advertisement
Latest Updated Articles
Ovarian Cancer: FDA Approved PARP InhibitorsPublished: January 20th 2021 | Updated:
- Genetic Testing for Ovarian Cancer
Published: January 20th 2021 | Updated:
- Role of Maintenance Therapy in Ovarian Cancer
Published: January 20th 2021 | Updated:
- Future Directions for Treatment of Ovarian Cancer
Published: January 20th 2021 | Updated:
- PAOLA-1 Trial
Published: January 20th 2021 | Updated:
- Selecting Maintenance Therapy in Ovarian Cancer
Published: January 20th 2021 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
Tarlatamab Plus Chemo/IO Regimens Are Safe, Elicit Responses in ES-SCLC
2
Tarlatamab Improves Survival Vs Chemotherapy in Second-Line SCLC Subgroups
3
Pembrolizumab Combo Significantly Improves PFS/OS in Recurrent PROC
4
Frontline Alectinib Upholds OS Benefit in Advanced ALK+ NSCLC
5
